Barbara Kosacz

Barbara A. Kosacz is currently Director at Biotechnology Innovation Organization, Independent Director at LeonaBio, Inc. since 2021, and Trustee at Keck Graduate Institute of Applied Life Sciences.
Former roles include Director at Arsenal Biosciences, Inc., Independent Director at Locust Walk Acquisition Corp.
in 2021, Independent Director at Phoenix Biotech Acquisition Corp., Independent Director at XOMA Royalty Corp.
from 2019 to 2026, Secretary at Cellerant Therapeutics, Inc., Moksha8 Pharmaceuticals, Inc., and NGM Biopharmaceuticals, Inc., Principal at Cooley Godward LLP, Vice President at iScribe, Inc. from 2001 to 2002, Head-International Life Sciences Practice at Cooley LLP from 2002 to 2020, Partner at Cooley LLP from 1997 to 2000, Member of the California State Bar Association, and COO, Secretary & General Counsel at Kronos Bio, Inc. from 2020 to 2024.
Education includes an undergraduate degree from Stanford University conferred in 1980 and a graduate degree from Berkeley Law University of California.